InsidersTradesSigma
Biotron Limited Stock: price and directors' dealings · Australia · ASX
Follow the Biotron Limited share price and the full insider trade history of the company, a publicly traded company based in Australia. Shares are quoted on AU AU, under the authority of ASX. Operating in the Health Care sector, Biotron Limited has logged 1 reports. Market capitalisation: €5.4m. The latest transaction was filed on 15 May 2026 (Other). Among the most active insiders: Mr Michael J. Hoy. All data is openly available.
1
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
9Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 15 May 2026
Declarations1 total
ShareASXASX:2924-03090484-2A1672245
1 of 1 declaration
About Biotron Limited
Biotron Limited is an Australian biopharmaceutical company focused on developing treatments for viral diseases and immune disorders. It is listed on the Australian Securities Exchange (XASX).
